News
Catch the latest news, research, and breakthroughs from Gradient™ Denervation Technologies.
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total [...]
Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
PARIS, May 19, 2025 (GLOBE NEWSWIRE) - Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough [...]
Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study
PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based catheter [...]
Gradient Denervation Technologies Enrolls First Patient in Early Feasibility Study of Pulmonary Artery Denervation System
FDA-Approved US study intended to evaluate pulmonary artery denervation in heart failure patients with WHO Group 2 Pulmonary Hypertension PARIS, [...]
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
Thuja Capital and founding investor Sofinnova Partners also joined the round The funds will enable the company to advance the [...]
Gradient Denervation Technologies enrolls initial patient in first-in-human study of pulmonary artery denervation technology
PARIS, FRANCE, JUNE 1, 2023 — Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating [...]
Gradient Denervation Technologies announces appointment of Martin Grasse as Chief Executive Officer
Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive solution for the treatment of heart failure patients with [...]
Gradient Denervation Technologies Raises €3.5M in Seed Funding with Sofinnova Partners
September 17, 2020 – Paris, France Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive solution for the [...]